Drägerwerk AG & Co. KGaA (pref) (DRW3) - Total Liabilities
Based on the latest financial reports, Drägerwerk AG & Co. KGaA (pref) (DRW3) has total liabilities worth €1.51 Billion EUR (≈ $1.76 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Drägerwerk AG & Co. KGaA (pref) (DRW3) long-term investment share to see how much of total assets are deployed in long-term investments.
Drägerwerk AG & Co. KGaA (pref) - Total Liabilities Trend (2013–2025)
This chart illustrates how Drägerwerk AG & Co. KGaA (pref)'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Drägerwerk AG & Co. KGaA (pref) total assets.
Drägerwerk AG & Co. KGaA (pref) Competitors by Total Liabilities
The table below lists competitors of Drägerwerk AG & Co. KGaA (pref) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Terveystalo Oy
HE:TTALO
|
Finland | €854.50 Million |
|
Aevis Victoria SA
SW:AEVS
|
Switzerland | CHF1.34 Billion |
|
Goldsun Building Materials Co Ltd
TW:2504
|
Taiwan | NT$23.15 Billion |
|
Altus Group Limited
TO:AIF
|
Canada | CA$537.21 Million |
|
Nokian Renkaat Oyj
HE:TYRES
|
Finland | €1.30 Billion |
|
Playtech plc
F:PL8
|
Germany | €823.30 Million |
|
MilDef Group AB
ST:MILDEF
|
Sweden | Skr1.53 Billion |
|
BHI Co. Ltd
KQ:083650
|
Korea | ₩719.46 Billion |
Liability Composition Analysis (2013–2025)
This chart breaks down Drägerwerk AG & Co. KGaA (pref)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Drägerwerk AG & Co. KGaA (pref) (DRW3) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.91 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.48 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Drägerwerk AG & Co. KGaA (pref)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Drägerwerk AG & Co. KGaA (pref) (2013–2025)
The table below shows the annual total liabilities of Drägerwerk AG & Co. KGaA (pref) from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €1.53 Billion ≈ $1.79 Billion |
-1.43% |
| 2024-12-31 | €1.56 Billion ≈ $1.82 Billion |
-7.64% |
| 2023-12-31 | €1.69 Billion ≈ $1.97 Billion |
-5.70% |
| 2022-12-31 | €1.79 Billion ≈ $2.09 Billion |
-6.81% |
| 2021-12-31 | €1.92 Billion ≈ $2.24 Billion |
-15.60% |
| 2020-12-31 | €2.27 Billion ≈ $2.66 Billion |
+52.03% |
| 2019-12-31 | €1.49 Billion ≈ $1.75 Billion |
+12.41% |
| 2018-12-31 | €1.33 Billion ≈ $1.55 Billion |
+3.39% |
| 2017-12-31 | €1.29 Billion ≈ $1.50 Billion |
-1.74% |
| 2016-12-31 | €1.31 Billion ≈ $1.53 Billion |
-4.15% |
| 2015-12-31 | €1.37 Billion ≈ $1.60 Billion |
+2.09% |
| 2014-12-31 | €1.34 Billion ≈ $1.56 Billion |
+7.08% |
| 2013-12-31 | €1.25 Billion ≈ $1.46 Billion |
-- |
About Drägerwerk AG & Co. KGaA (pref)
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas m… Read more